Ron Bonner

Dr. Ron Bonner

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Analytica Chimica Acta
Verified
Journal Article
Open access
ADAnita O. Ducati
Anita O. Ducati
DRDavid Ruskic
David Ruskic
PSPiotr Sosnowski
Piotr Sosnowski
TBTakashi Baba
Takashi Baba
RBRon Bonner
Ron Bonner
GHGérard Hopfgartner
Gérard Hopfgartner
Using a chimeric collision cell mounted on a quadrupole time-of-flight platform, collision induced dissociation (CID) and electron induced dissociation (EID) were investigated for the LC-MS analysis of low molecular weight compounds including drugs and endogenous metabolites. Compared to CID, EID fragmentation of the [M+H]+ species (10-20 eV) from standard compounds resulted in additional specific and informative fragments, mostly due to neutral losses and, in some cases due to ring openings. Some analytes, for example reserpine and vinpocetine, provided characteristic [M+H]•2+ species. For most analytes for sodium and potassium adducts and multimers a radical cation M•+ and electron impact type fragments were observed in the EID spectra, providing the opportunity to use EI libraries to support metabolite identification. EID opens the possibility to get structural information from adduct ions which is often not the case with CID. EID enabled the putative characterization of two metabolites in rat urine as glucuronides of 5,6-dihydroxyindole based on EID fragmentation of the potassium adducts.

1 July 2021 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
FKFrank Klont
Frank Klont
DKDaan Kremer
Daan Kremer
ANAntonio W. Gomes Neto
Antonio W. Gomes Neto
S.P. BergerS.P. Berger
S.P. Berger
Daniel Johannes TouwDaniel Johannes Touw
Daniel Johannes Touw
GHGérard Hopfgartner
Gérard Hopfgartner
The objective of this study was to investigate whether clinical metabolomics, which is increasingly applied in population-based and epidemiological studies, can be used to provide analytical evidence of exposures, and whether such information can be useful to strengthen and/or complement corresponding clinical database entries, taking drug use as an example. Liquid chromatography-mass spectrometry (LC-MS) metabolomics analyses were performed on urine from 100 randomly-selected control subjects (50% females) from the TransplantLines Food and Nutrition Biobank and Cohort Study (NCT identifier 'NCT02811835'), and drugs were identified through spectral library searching and targeted signal extraction. In 83 subjects for whom drug use information was available, 22 expected and 26 unexpected prescription-only drugs were identified, while 28 expected prescription-only drugs remained undetected. In addition, 7 prescription-only drugs were found in 17 subjects for whom drug use information was unavailable, and 58 over-the-counter drugs were identified in all 100 subjects. Molecular evidence for many drugs could be retrieved from LC-MS metabolomics data, which could be useful to complement and strengthen epidemiological databases given that considerable discrepancies were found between analytically-identified drugs and drugs listed in the available clinical database.

1 February 2022 in Analytica Chimica Acta
Verified
Journal Article
Open access
RBRon Bonner
Ron Bonner
GHGérard Hopfgartner
Gérard Hopfgartner
Annotating electrospray small molecule mass spectra remains a challenging problem due to the multiple processes occurring during ionization. Although an [M+H]+ is often present, ions can be formed by reactions with other cations, background compounds and co-eluting species, and by in-source fragmentation. Even single analytes can produce multiple ion forms, many of which remain unidentified and may appear to be different species, affecting reproducibility, quantification and precursor selection in DDA experiments. Annotation usually compares differences between peaks to known adducts and losses but fails if key peaks are missing or if the peaks are from unexpected adducts. Further, isotopes are often assumed to be due to 13C and removed prior to analysis which can leave 'orphan' peaks if unusual elements are present. Here we describe an alternative multi-layered approach (MLA) which successively matches spectra to calculated target ion lists and reprocesses the residual ions. This allows the analyst to focus on the unknown ions and to progressively increase target list complexity since explained ions are removed. Target ion lists can be calculated from expected or observed masses and potential adducts or can be pre-defined lists, for example common contaminants. Using this approach on spectra of known standards we identified adducts with Ca, Al, Fe, Ba and possibly Mg and Sr. We also detected several compounds and adducts in a spectrum of co-eluting species from an LC-MS analysis.

1 July 1998 in Medical Physics
Verified
Journal Article
Closed access
Israel GannotIsrael Gannot
Israel Gannot
RBRon Bonner
Ron Bonner
GGG. Gannot
G. Gannot
PFP. C. Fox
P. C. Fox
PSP. D. Smith
P. D. Smith
AGAmir Gandjbakhche
Amir Gandjbakhche

4 October 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
FKFrank Klont
Frank Klont
PSPiotr Sosnowski
Piotr Sosnowski
DKDaan Kremer
Daan Kremer
TKT.J. Knobbe
T.J. Knobbe
RBRon Bonner
Ron Bonner
GHGérard Hopfgartner
Gérard Hopfgartner
Mass spectrometry (MS) is increasingly used in clinical studies to obtain molecular evidence of chemical exposures, such as tobacco smoke, alcohol, and drugs. This evidence can help verify clinical data retrieved through anamnesis or questionnaires and may provide insights into unreported exposures, for example those classified as the same despite small but possibly relevant chemical differences or due to contaminants in reported exposure compounds. Here, we aimed to explore the potential of untargeted SWATH metabolomics to differentiate such closely related exposures. This data-independent acquisition MS-based profiling technique was applied to urine samples of 316 liver and 570 kidney transplant recipients from the TransplantLines Biobank and Cohort Study (NCT03272841), where we focused on the immunosuppressive drug mycophenolate, which is either supplied as a morpholino-ester prodrug or as an enteric-coated product, the illicit drug cocaine, which is usually supplied as an adulterated product, and the proton pump inhibitors omeprazole and esomeprazole. Based on these examples, we found that untargeted SWATH metabolomics has considerable potential to identify different (unreported) exposure or co-exposure metabolites and may determine variations in their abundances. We also found that these signals alone may sometimes be unable to distinguish closely related exposures, and enhancement of differentiation, for example by integration with pharmacogenomics data, is needed.

28 April 2011 in BMC Proceedings
Verified
Journal Article
Open access
PDF file
MEMartin Ehler
Martin Ehler
VRVinodh N Rajapakse
Vinodh N Rajapakse
BZBarry R Zeeberg
Barry R Zeeberg
BBBrian P Brooks
Brian P Brooks
JBJacob Brown
Jacob Brown
RBRon Bonner
Ron Bonner
The gene networks underlying closure of the optic fissure during vertebrate eye development are not well-understood. We use a novel clustering method based on nonlinear dimension reduction with data labeling to analyze microarray data from laser capture microdissected (LCM) cells at the site and developmental stages (days 10.5 to 12.5) of optic fissure closure.